Literature DB >> 16009674

Influence of IL-6, COL1A1, and VDR gene polymorphisms on bone mineral density in Crohn's disease.

C E Todhunter1, A Sutherland-Craggs, S A Bartram, P T Donaldson, A K Daly, R M Francis, J C Mansfield, N P Thompson.   

Abstract

BACKGROUND: Osteoporosis is an important cause of morbidity in patients with Crohn's disease. The pathogenesis of reduced bone mineral density (BMD) is multifactorial. A range of genetic factors have been implicated in other populations of patients with osteoporosis. AIM: To investigate the influence of interleukin 6 (IL-6), collagen type 1alpha1 (COL1A1), and vitamin D receptor gene (VDR) single nucleotide polymorphisms (SNP) on BMD in patients with Crohn's disease. PATIENTS: A cohort of 245 well characterised patients with Crohn's disease were recruited from the inflammatory bowel disease register at the Freeman Hospital and Royal Victoria Infirmary, Newcastle upon Tyne, and the Queen Elizabeth Hospital, Gateshead, UK.
METHODS: Patients were genotyped for IL-6 C-174G SNP, COL1A1 Sp1 binding site G T SNP, VDR Taq1, and Fok1 SNPs, and CARD15 R702W, G908R, and L1007fs SNPs. BMD was measured at the lumbar spine (LSP) and hip using dual energy x ray absorptiometry.
RESULTS: A total of 158 female and 87 male patients, aged 24-70 years (mean 44), were recruited. There were no significant differences in the distribution of the tested SNPs when analysed for age, body mass index, pre/post-menopausal status, smoking, or steroid use. Two hundred and thirteen patients were genotyped for the IL-6 SNP. LSP and total hip BMD was significantly lower in patients with the GG genotype (48%) than the CC genotype (15%) (p = 0.041, p = 0.014). One hundred and eighty patients were genotyped for the COL1A1 SNP. There was no significant difference in BMD at LSP. Hip BMD was significantly lower in heterozygous patients compared with homozygous wild-types (p = 0.034). There were no significant differences in BMD between genotypes for the two VDR SNPs or the CARD15 genotypes examined.
CONCLUSION: IL-6 and COL1A1 gene polymorphisms influence BMD in patients with Crohn's disease but the particular VDR gene polymorphisms studied do not have a major effect.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16009674      PMCID: PMC1774753          DOI: 10.1136/gut.2005.064212

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  45 in total

1.  Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group.

Authors:  J A Kanis
Journal:  Osteoporos Int       Date:  1994-11       Impact factor: 4.507

Review 2.  The role of IL-6 type cytokines and their receptors in bone.

Authors:  S C Manolagas
Journal:  Ann N Y Acad Sci       Date:  1998-05-01       Impact factor: 5.691

Review 3.  Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis.

Authors:  S C Manolagas; R L Jilka
Journal:  N Engl J Med       Date:  1995-02-02       Impact factor: 91.245

4.  Bone mineral density in relation to polymorphism at the vitamin D receptor gene locus.

Authors:  F G Hustmyer; M Peacock; S Hui; C C Johnston; J Christian
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

5.  Relation of alleles of the collagen type Ialpha1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women.

Authors:  A G Uitterlinden; H Burger; Q Huang; F Yue; F E McGuigan; S F Grant; A Hofman; J P van Leeuwen; H A Pols; S H Ralston
Journal:  N Engl J Med       Date:  1998-04-09       Impact factor: 91.245

6.  Long-term prediction of incident hip fracture risk in elderly white women: study of osteoporotic fractures.

Authors:  Brent C Taylor; Pamela J Schreiner; Katie L Stone; Howard A Fink; Steven R Cummings; Michael C Nevitt; Paula J Bowman; Kristine E Ensrud
Journal:  J Am Geriatr Soc       Date:  2004-09       Impact factor: 5.562

Review 7.  Role of cytokines in bone resorption.

Authors:  S C Manolagas
Journal:  Bone       Date:  1995-08       Impact factor: 4.398

8.  Calcium absorption on high and low calcium intakes in relation to vitamin D receptor genotype.

Authors:  B Dawson-Hughes; S S Harris; S Finneran
Journal:  J Clin Endocrinol Metab       Date:  1995-12       Impact factor: 5.958

9.  Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures.

Authors:  D Marshall; O Johnell; H Wedel
Journal:  BMJ       Date:  1996-05-18

10.  Influence of vitamin D receptor genotype on bone mineral density in postmenopausal women: a twin study in Britain.

Authors:  T D Spector; R W Keen; N K Arden; N A Morrison; P J Major; T V Nguyen; P J Kelly; J R Baker; P N Sambrook; J S Lanchbury
Journal:  BMJ       Date:  1995-05-27
View more
  9 in total

1.  Osteoporosis in adult Sri Lankan inflammatory bowel disease patients.

Authors:  Arjuna Priyadarsin de Silva; Aranjan Lionel Karunanayake; Thalahitiya Gamaralalage Iruka Dissanayaka; Anuradha Supun Dassanayake; Hewa Kattadi Kankanamgae Tilak Duminda; Arunasalam Pathmeswaran; Ananda Rajitha Wickramasinghe; Hithanadura Janaka de Silva
Journal:  World J Gastroenterol       Date:  2009-07-28       Impact factor: 5.742

Review 2.  Role of genetics in the diagnosis and prognosis of Crohn's disease.

Authors:  Epameinondas V Tsianos; Konstantinos H Katsanos; Vasileios E Tsianos
Journal:  World J Gastroenterol       Date:  2011-12-28       Impact factor: 5.742

3.  Bones and Crohn's: no benefit of adding sodium fluoride or ibandronate to calcium and vitamin D.

Authors:  Jochen Klaus; Max Reinshagen; Katharina Herdt; Christoph Schröter; Guido Adler; Georg Bt von Boyen; Christian von Tirpitz
Journal:  World J Gastroenterol       Date:  2011-01-21       Impact factor: 5.742

Review 4.  Inflammatory bowel diseases as secondary causes of osteoporosis.

Authors:  Charles N Bernstein
Journal:  Curr Osteoporos Rep       Date:  2006-09       Impact factor: 5.096

Review 5.  Role of genetics in the diagnosis and prognosis of Crohn's disease.

Authors:  Epameinondas V Tsianos; Konstantinos H Katsanos; Vasileios E Tsianos
Journal:  World J Gastroenterol       Date:  2012-01-14       Impact factor: 5.742

6.  The polymorphism of Insulin-like growth factor-I (IGF-I) is related to osteoporosis and bone mineral density in postmenopausal population.

Authors:  Li Yun-Kai; Wang Hui; Zhu Xin-Wei; Guo Liang; Zuo Jin-Liang
Journal:  Pak J Med Sci       Date:  2014-01       Impact factor: 1.088

7.  Efficacy and safety of bisphosphonates in management of low bone density in inflammatory bowel disease: A meta-analysis.

Authors:  Liwei Yao; Haiqing Wang; Wenwei Dong; Zhenxin Liu; Haijiao Mao
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

Review 8.  Bone alterations in inflammatory bowel diseases.

Authors:  Dolores Sgambato; Francesca Gimigliano; Cristiana De Musis; Antimo Moretti; Giuseppe Toro; Emanuele Ferrante; Agnese Miranda; Domenico De Mauro; Lorenzo Romano; Giovanni Iolascon; Marco Romano
Journal:  World J Clin Cases       Date:  2019-08-06       Impact factor: 1.337

Review 9.  Mechanisms Underlying Bone Loss Associated with Gut Inflammation.

Authors:  Ke Ke; Manoj Arra; Yousef Abu-Amer
Journal:  Int J Mol Sci       Date:  2019-12-15       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.